National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

MAGE-10.A2
A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Lyrica, lyso-thermosensitive liposome doxorubicin, Lysodren, m-azidopyrimethamine, mafosfamide
Next:MAGE-A3/HPV 16 peptide vaccine, magnesium citrate, magnesium hydroxide, magnesium valproate, Magnevist

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov